Le Lézard
Classified in: Health, Science and technology, Business
Subject: TNM

Remedy Health Media Acquires OBR Oncology

NEW YORK, Sept. 22, 2020 /PRNewswire/ -- Remedy Health Media (Remedy), a leading digital health platform and portfolio company of Topspin Consumer Partners, today announced the acquisition of OBR (Oncology Business Review), an oncology-focused digital media company that provides news and information resources to oncologists and oncology healthcare professionals (HCPs). OBR is a leading resource for the entire oncology team, reaching an audience of more than 25,000 members daily. Combining OBR's leadership position in the oncology space with Remedy's broader reach and resources creates an opportunity to grow both audience and impact across the oncology landscape. OBR extends the company's existing network of trusted digital health brands for consumers and healthcare professionals.

As the oncology landscape continues to evolve with significant advancements in treatment and patient care rooted in research, the acquisition of OBR provides Remedy a powerful platform to educate, raise awareness of research advancements, and play an important role in the dialogue between patients and professionals.

"The addition of OBR allows Remedy to serve the oncology community in powerful ways by providing instant access to leading opinions and the most current medical information for oncology professionals," said Remedy CEO, Mike Cunnion. "Aligning ourselves with innovative partners like OBR, which has been serving the oncology community for more than a decade, helps us amplify our mission and motivate communities of patients and professionals towards optimal patient care." Cunnion added, "We are excited to welcome the terrific OBR team to Remedy."

"OBR has been serving the oncology community for more than 13 years, and our brand and presence amongst oncology providers and professionals is strong," said Founder and President of OBR, Don Sharpe. "We were well poised for a partner that would help us become even stronger in the creation and delivery of actionable oncology information. In Remedy, we have found a partner with a track record of success in creating and publishing important healthcare information, a robust digital presence, and the resources to help us maximize our potential."

As an innovative healthcare media company, OBR will help strengthen Remedy's overall HCP capabilities through its vast network of relevant key opinion leaders, market access training platform, and a wide range of digital media resources delivering current and relevant oncology information.

"As a leading authority in oncology news for healthcare professionals with unparalleled relationships across oncology stakeholders, the acquisition of OBR provides both a distinctive and fundamental platform to help Remedy grow and further serve its audience and partners," said Leigh Randall, Managing Partner at Topspin Consumer Partners.

About Remedy Health Media

Remedy Health Media (Remedy) is a leading digital platform that serves communities of patients, care partners and healthcare professionals through a family of trusted health brands that exist to remove barriers to better health. Remedy Health Media owns and operates HealthCentral, TheBody, TheBodyPro, PsyCom, Berkeley Wellness, EndocrineWeb, Practical Pain Management, and Spine Universe. To learn more visit RemedyHealthMedia.com.

About Topspin Consumer Partners

Topspin Consumer Partners is a Mamaroneck, NY-based private equity firm that makes investments in established, profitable and fast-growing middle-market consumer businesses. The firm invests across a number of sub-verticals within consumer, including health and wellness, personal care and beauty, household goods, digital media, pet, juvenile products, and food and beverage. The Topspin team has considerable operational expertise and collaborates with founder-owners and management teams to build businesses of varying stages and sizes. Further information on Topspin can be found at www.topspincp.com.

Media Contact:
Carrie Kreiswirth

SOURCE Remedy Health Media

These press releases may also interest you

at 20:00
NeuroSigma, Inc., a Los Angeles-based bioelectronics company focused on commercializing Trigeminal Nerve Stimulation (TNS) technology for treating neurological and neuropsychiatric disorders announces the publication on October 14, 2020 in the...

at 19:49
The Lake Charles community has been ravaged by hurricanes this year! That, coupled with a worldwide pandemic, has left us battered and shell shocked, but we WILL prevail. In response, Centex Studies and several other businesses in the local community...

at 19:21
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the third quarter ended September 30, 2020. All figures included herein are stated in nominal Mexican pesos and have been...

at 18:33
The board of directors of NeoDynamics AB ("NeoDynamics" or the "Company") proposes that an extraordinary general meeting is convened to resolve on a directed new share issue to a limited group of investors (the "Share Issue"). The subscription price...

at 18:20
Shattuck Labs, Inc. ("Shattuck"), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced...

at 18:00
In a civil lawsuit, Crook County Circuit Court in Oregon awarded $21.5 million to Nicholas Ricks, who suffered severe and permanent injuries in a near-fatal shooting, as cited the Complaint for case 19CV56324. In December 2019, Ricks' attorneys filed...

News published on 22 september 2020 at 10:15 and distributed by: